ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZN Astrazeneca Plc

11,988.00
-38.00 (-0.32%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -38.00 -0.32% 11,988.00 12,014.00 12,018.00 12,144.00 11,882.00 12,070.00 2,340,814 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.28 186.27B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,026p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,210.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £186.27 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.28.

Astrazeneca Share Discussion Threads

Showing 6076 to 6098 of 6150 messages
Chat Pages: 246  245  244  243  242  241  240  239  238  237  236  235  Older
DateSubjectAuthorDiscuss
08/2/2024
15:33
Should has stated, dipped in at £97.70.7
beckers2008
08/2/2024
15:31
I've been waiting patiently and finally been able to buy back in here, after a few years.
SP reaction,overdone today, hopefully luckily for me? Let's wait and see.

beckers2008
08/2/2024
14:55
‘Many investors view AstraZeneca as invincible given its success in recent years, yet its latest results showed that even the mighty can disappoint. The drugs giant missed fourth quarter earnings expectations due to more money being spent on research and development and a greater contribution from lower-margin sales in emerging markets. However, the business remains optimistic about the prospects for its cancer and rare disease drugs,’ AJ Bell analyst Russ Mould commented.
philanderer
08/2/2024
14:38
Poor divi in present 5% money market funds environment. Great company but well heeled managers, along with scores of other companies paying 2-3% need to get real. The boards of these businesses don't give a f..k about shareholders-they are so well paid in any case. No recovery here until rates drop to 3%
cumnor
08/2/2024
14:35
Yep the yanks pushing this further down
chc15
08/2/2024
14:20
Just topped up, I read that the fall relates to them missing Q4 projections, just, but against the 2024-5 forecast and rest of year it seems overdone
faz
08/2/2024
14:06
seems a heavy fall on results that weren't that bad. took a small position to start
ric0chet
08/2/2024
12:28
Looks well overdone to me. IMO it will recover
our haven
08/2/2024
12:07
Me too.
Suet

suetballs
08/2/2024
11:42
Yeh just had a nibble at 98, then waiting for US to open and see..
chc15
08/2/2024
11:35
Can't be far off now, surely.
Might have another little plummet when stateside opens.

thamestrader
08/2/2024
11:14
Ouch, what's the bottom here u think..
chc15
08/2/2024
10:43
vaston. Grow up.
tday
08/2/2024
10:34
SYME IS NOW READY TO FLY
vaston
08/2/2024
10:21
Continues to disappoint.
philanderer
08/2/2024
09:14
Dounbtless if profits halved market would raise price by £2.50
holts
29/1/2024
15:32
https://www.londonstockexchange.com/news-article/APH/full-year-trading-update/16307097
blackhorse23
19/1/2024
11:52
Ha ha https://www.alliancepharmaceuticals.com/
blackhorse23
18/1/2024
19:46
We know you love APH but please stop pushing it everywhere!
mattboxy
18/1/2024
14:23
Bought some APH today
blackhorse23
17/1/2024
01:18
"So far everything is going very well" always make me think of a guy falling off the roof of a big tower when he's half way down
smcni1968
16/1/2024
11:00
For the last six months,AZN has traded fairly predictably between £100 to £110.
steeplejack
16/1/2024
10:29
UBS cuts AstraZeneca to 'sell' (buy) - price target 10,700 (13,000) pence

or..


Morgan Stanley raises AstraZeneca price target to 13,400 (12,900) pence - 'overweight'

philanderer
Chat Pages: 246  245  244  243  242  241  240  239  238  237  236  235  Older

Your Recent History

Delayed Upgrade Clock